Position
Fidelity in Rhythm Pharmaceuticals, Inc.
Back to the book · All holders of RYTM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $24.7M$86.97 → $111.03
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.71M | $182.6M | — | — | — | 0.0% |
| Q1 2026 | 1.69M | $147M | $86.97 | −$33.9M | −$1.78M | 0.0% |
| Q2 2026 | 1.03M | $113.9M | $111.03 | $24.7M | −$57.7M | 0.0% |